Tilray Brands Inc (TLRY) FinancialsTLRYTilray Brands Inc

Tilray Brands Inc (TLRY) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Beverage Alcohol Business, accounting for 37.5% of total sales, equivalent to $105.60M. Other significant revenue streams include Distribution Business and Cannabis Business. Understanding this composition is critical for investors evaluating how TLRY navigates market cycles within the Pharmaceuticals industry.

Evaluating the bottom line, Tilray Brands Inc maintains a gross margin of 29.93%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -1.60%, while the net margin is -13.46%. These profitability ratios, combined with a Return on Equity (ROE) of -7.77%, provide a clear picture of how effectively TLRY converts its operational activities into shareholder value.

In the context of the broader market, TLRY competes directly with industry leaders such as CGC and GLAS. With a market capitalization of $642.50M, it holds a significant position in the sector. When comparing efficiency, TLRY's gross margin of 29.93% stands against CGC's 27.40% and GLAS's 26.22%. Such benchmarking helps identify whether Tilray Brands Inc is trading at a premium or discount relative to its financial performance.

Tilray's total revenue for FY 2026 reached approximately $915 million, reflecting an 11% increase. However, the company reported a net loss of $49.6 million, or negative $0.43 per share, indicating ongoing financial strain. The gross margin has improved to 29.93%, which is a positive sign, but the overall financial health remains fragile.